Your browser doesn't support javascript.
loading
Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial.
Kantarjian, Hagop M; Fenaux, Pierre; Sekeres, Mikkael A; Szer, Jeffrey; Platzbecker, Uwe; Kuendgen, Andrea; Gaidano, Gianluca; Wiktor-Jedrzejczak, Wieslaw; Carpenter, Nancy; Mehta, Bhakti; Franklin, Janet; Giagounidis, Aristoteles.
Affiliation
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: hkantarjian@mdanderson.org.
  • Fenaux P; Service d'Hématologie Clinique, Assistance Publique-Hôpitaux de Paris, Hôpital St Louis, Université Paris 7, Paris, France.
  • Sekeres MA; Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Szer J; Clinical Haematology, Royal Melbourne Hospital and Department of Medicine, University of Melbourne, Melbourne, Australia.
  • Platzbecker U; Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, Medizinische Klinik und Poliklinik I, Dresden, Germany.
  • Kuendgen A; Sprechstunde für MDS, AML und Myelofibrose, Klinik für Hämatologie, Onkologie und klinische Immunologie, Heinrich-Heine-University of Düsseldorf, Medizinische Klinik und Poliklinik A, Düsseldorf, Germany.
  • Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Wiktor-Jedrzejczak W; Medical University of Warsaw, Warsaw, Poland.
  • Carpenter N; Amgen Ltd, Uxbridge, Middlesex, UK.
  • Mehta B; Amgen Inc, Thousand Oaks, CA, USA.
  • Franklin J; Amgen Inc, Thousand Oaks, CA, USA.
  • Giagounidis A; Klinik für Onkologie, Hämatologie und Palliativmedizin, Marien Hospital, Düsseldorf, Germany.
Lancet Haematol ; 5(3): e117-e126, 2018 Mar.
Article in En | MEDLINE | ID: mdl-29396092

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Thrombopoietin / Myelodysplastic Syndromes / Recombinant Fusion Proteins / Receptors, Fc / Leukemia, Myeloid, Acute Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Lancet Haematol Year: 2018 Document type: Article Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Thrombopoietin / Myelodysplastic Syndromes / Recombinant Fusion Proteins / Receptors, Fc / Leukemia, Myeloid, Acute Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Lancet Haematol Year: 2018 Document type: Article Country of publication: Reino Unido